Patents by Inventor Nobuhiko DOJUN

Nobuhiko DOJUN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250129129
    Abstract: To control plant diseases caused by Xanthomonas spp., a novel bacteriophage exhibiting bacteriolysis activity specifically on Xanthomonas spp. was isolated. Thus, developed and provided is a plant disease control composition containing the bacteriophage as an active ingredient. Provided are a bacteriolytic agent containing a bacteriophage that has a novel genomic DNA sequence and exhibits bacteriolysis activity specifically on Xanthomonas spp., and a plant disease control composition containing the same as an active ingredient.
    Type: Application
    Filed: September 30, 2024
    Publication date: April 24, 2025
    Applicants: KANEKA CORPORATION, RAKUNO GAKUEN UNIVERSITY, MITSUI & CO., LTD.
    Inventors: Shinichi Yoshida, Nobuhiko Dojun, Mitsuaki Kitano, Hidetomo Iwano, Hitoshi Kudo
  • Publication number: 20250089724
    Abstract: To control plant diseases caused by Xanthomonas spp., a novel bacteriophage exhibiting bacteriolysis activity specifically on Xanthomonas spp. was isolated. Thus, developed and provided is a plant disease control composition containing the bacteriophage as an active ingredient. Provided are a bacteriolytic agent containing a bacteriophage that has a novel genomic DNA sequence and exhibits bacteriolysis activity specifically on Xanthomonas spp., and a plant disease control composition containing the same as an active ingredient.
    Type: Application
    Filed: September 27, 2024
    Publication date: March 20, 2025
    Applicants: KANEKA CORPORATION, RAKUNO GAKUEN UNIVERSITY, MITSUI & CO., LTD.
    Inventors: Shinichi Yoshida, Nobuhiko Dojun, Mitsuaki Kitano, Hidetomo Iwano, Hitoshi Kudo
  • Publication number: 20250090608
    Abstract: To control plant diseases caused by Xanthomonas spp., a novel bacteriophage exhibiting bacteriolysis activity specifically on Xanthomonas spp. was isolated. Thus, developed and provided is a plant disease control composition containing the bacteriophage as an active ingredient. Provided are a bacteriolytic agent containing a bacteriophage that has a novel genomic DNA sequence and exhibits bacteriolysis activity specifically on Xanthomonas spp., and a plant disease control composition containing the same as an active ingredient.
    Type: Application
    Filed: September 27, 2024
    Publication date: March 20, 2025
    Applicants: KANEKA CORPORATION, RAKUNO GAKUEN UNIVERSITY, MITSUI & CO., LTD.
    Inventors: Shinichi Yoshida, Nobuhiko Dojun, Mitsuaki Kitano, Hidetomo Iwano, Hitoshi Kudo
  • Publication number: 20250089725
    Abstract: To control plant diseases caused by Xanthomonas spp., a novel bacteriophage exhibiting bacteriolysis activity specifically on Xanthomonas spp. was isolated. Thus, developed and provided is a plant disease control composition containing the bacteriophage as an active ingredient. Provided are a bacteriolytic agent containing a bacteriophage that has a novel genomic DNA sequence and exhibits bacteriolysis activity specifically on Xanthomonas spp., and a plant disease control composition containing the same as an active ingredient.
    Type: Application
    Filed: September 30, 2024
    Publication date: March 20, 2025
    Applicants: KANEKA CORPORATION, RAKUNO GAKUEN UNIVERSITY, MITSUI & CO., LTD.
    Inventors: Shinichi Yoshida, Nobuhiko Dojun, Mitsuaki Kitano, Hidetomo Iwano, Hitoshi Kudo
  • Publication number: 20230304061
    Abstract: This invention is intended to improve glutathione productivity by fermentation using microorganisms. This invention relates to a microbial strain capable of overexpression of ?-glutamylcysteine, bis-?-glutamylcystine, ?-glutamylcystine, reduced glutathione, and/or oxidized glutathione in which the expression level of a gene encoding serine-O-acetyltransferase (EC:2.3.1.30) is enhanced and a method involving the use of such microbial strain.
    Type: Application
    Filed: April 23, 2021
    Publication date: September 28, 2023
    Applicant: KANEKA CORPORATION
    Inventors: Shingo KOBAYASHI, Nobuhiko DOJUN, Misato MATSUI, Naoaki TAOKA